Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.

× No keyword cloud information.

23 in total

1. Preclinical imaging characteristics and quantification of Platinum-195m SPECT.

Authors: E A Aalbersberg; B J de Wit-van der Veen; O Zwaagstra; K Codée-van der Schilden; E Vegt; Wouter V Vogel
Journal: Eur J Nucl Med Mol Imaging Date: 2017-02-11 Impact factor: 9.236

Review 2. Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors: R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal: Drugs Date: 1978-07 Impact factor: 9.546

Review 3. Platinum antitumour agents: a review of (bio)analysis.

Authors: T J Hodes; W J Underberg; G Los; J H Beijnen
Journal: Pharm Weekbl Sci Date: 1992-06-19

4. Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.

Authors: B Hecquet; P Vennin; C Fournier; J L Lefebvre; A Caty; J Bonneterre; L Adenis; A Demaille
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

5. Cisplatin disposition in children and adolescents with cancer.

Authors: W R Crom; W E Evans; C B Pratt; N Senzer; M Denison; A A Green; F A Hayes; G C Yee
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

Review 6. Pharmacokinetics of anticancer drugs in children.

Authors: W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal: Clin Pharmacokinet Date: 1987-03 Impact factor: 6.447

7. Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.

Authors: J J Gullo; C L Litterst; P J Maguire; B I Sikic; D F Hoth; P V Woolley
Journal: Cancer Chemother Pharmacol Date: 1980 Impact factor: 3.333

8. A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II).

Authors: R Harrison; C A McAuliffe; A Zaki; J Baer; H Sharma; A Smith; H Jackson; B W Fox
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

9. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

Authors: E M Hiesiger; S B Green; W R Shapiro; P C Burger; R G Selker; M S Mahaley; J Ransohoff; J C VanGilder; J Mealey; J T Robertson
Journal: J Neurooncol Date: 1995 Impact factor: 4.130

10. Serum albumin (SA) accumulation by bronchogenic tumours: a tracer technique may help with patient selection for SA-delivered chemotherapy.

Authors: J H Clorius; H Sinn; H G Manke; H H Schrenk; J Blatter; C Werling; E A Friedrich; J Voges; M Bahner; V Sturm
Journal: Eur J Nucl Med Date: 1995-09